Lv41
401 积分 2024-10-11 加入
Simultaneous surgery for NMIBC and BOO: Evaluating surgical safety to oncological benefit. Evidence from a systematic review and meta-analysis
33分钟前
已关闭
Guidelines from the cancer (CCAFU) and infection disease (CI-AFU) committees of the French Association of Urology for the management of adverse events and complications of BCG
1个月前
已完结
Clinical outcomes of BCG infections in patients undergoing intravesical immunotherapy for non-muscle-invasive bladder cancer: a systematic review and meta-analysis
1个月前
已完结
Mycobacterium bovis Infections Following Intravesical Bacillus Calmette-Guérin Instillation for Bladder Cancer in Western Australia: A 22-Year Retrospective Review
1个月前
已关闭
Endoscopic visual cues of intrarenal pressure during ureteroscopy: in vivo porcine studies
2个月前
已完结
Advances in fragment removal devices in ureteroscopy: up-to-date review
2个月前
已完结
RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2-positive locally advanced muscle-invasive urothelial bladder cancer: a multi-center phase Ib/II study (HOPE-03)
3个月前
已完结
Neoadjuvant treatment with disitamab vedotin plus perioperative toripalimab in patients with muscle-invasive bladder cancer (MIBC) with HER2 expression: Updated efficacy and safety results from the phase II RC48-C017 trial
3个月前
已完结
Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer
3个月前
已完结
A New Standard in Muscle-Invasive Bladder Cancer — The End of the Cisplatin Era?
3个月前
已完结